BIRC3 and B-cell chronic lymphocytic leukemia: Therefore, the mutational inactivation or deletion of BIRC3 in CLL results in constitutive NF-κB pathway activation, providing pro-survival signals to the leukemic clone, e.g., through the up-regulation of several anti-apoptotic genes, as demonstrated in ex vivo models [34,73].